Dramatic Moment at Trump Event as Weight Loss Drug Price Cuts Announced
A White House press conference took a startling turn thursday when an attendee collapsed near Donald Trump as the former president announced agreements to lower the cost of popular weight loss medications. the attendee, identified by White House spokesperson Karoline Leavitt as a representative from a pharmaceutical company, briefly fainted but is now reported to be “okay” after immediate intervention from the White House medical unit. Initial online speculation suggested the individual was a manager from Novo Nordisk, the manufacturer of Ozempic, but this has not been confirmed.
Despite the disruption, the press conference resumed after a short break. Trump described the attendee as “a little dazed.”
The primary focus of the event was Trump’s announcement of deals with Eli Lilly and Novo Nordisk to substantially reduce the price of their appetite suppressants, Zepbound and Wegovy, for american patients. Trump hailed the agreements as “a triumph…that will save lives and improve the health of millions.”
currently,weight-loss injections can cost US citizens over $1,000 per month. Under the new agreements,prices are expected to fall to around $350 per month.Newly approved weight loss pills could be available for approximately $150 per month.
The price reductions will be accessible starting in January through a government website, TrumpRx.gov,and are intended to benefit seniors and low-income individuals covered by Medicare and medicaid. In exchange for the lower prices, Trump pledged to offer Eli Lilly and Novo nordisk reduced import tariffs and expedited approval processes.
Trump has consistently criticized the higher cost of prescription drugs in the US compared to Europe and has been actively pressuring pharmaceutical companies to lower prices, notably given the high rates of obesity in the United states.
